Clinical trials: Volume Loss (Soft Tissue Ptosis or Atrophy ), active
Volume Loss (Soft Tissue Ptosis or Atrophy )
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
The goal of this clinical trial is to evaluate the potential of Calcium Hydroxylapatite (CaHA) to restore facial volume and improve skin quality in patients with GLP-1 receptor agonist-associated facial volume loss.
- Trial name
- NCT07419854
- Testing
- Hyperdiluted Calcium Hydroxylapatite, Calcium hydroxylapatite, Calcium hydroxylapatite with integral lidocaine
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Kalpna Kay Durairaj, MD, FACS